Target intelligence / Profile preview

HEN methyltransferase 1 (HENMT1)

Target
HENMT1
Molecular classification
Enzyme, Methyltransferase, RNA modification enzyme
01

Overview

HEN methyltransferase 1 (HENMT1) is a small RNA 2'-O-methyltransferase enzyme that catalyzes the methylation of the 2'-hydroxyl group at the 3'-end of PIWI-interacting RNAs (piRNAs) as well as some noncanonical tRNA-, rRNA-, and snRNA-derived small RNAs in mammals. This methylation protects piRNAs from terminal uridylation and subsequent degradation, ensuring their stability and function in post-transcriptional gene silencing, transposon repression, and genome stability, especially in the germline during spermatogenesis. The protein contains a conserved methyltransferase domain and is predominantly active in the cytoplasm and nucleus, with crucial roles demonstrated in mouse spermatogonial stem cells. Defects in HENMT1 activity are associated with impaired gametogenesis and possible links to infertility and neurological function[1][2][3][4].

Other names
Small RNA 2'-O-methyltransferaseC1orf59FLJ30525HEN1HEN1 methyltransferase homolog 1hua enhancer 1 homolog 1 (Arabidopsis)hua enhancer 1 homolog 1
02

Biological functions

RNA methylationStabilization of small noncoding RNAs (piRNAs, tRNA-derived, rRNA-derived, and snRNA-derived small RNAs)Protection of piRNA 3'-end from uridylation and degradationRegulation of gene expression in spermatogenesis and gametogenesis
03

Disease associations

Male infertility (e.g. azoospermia)Association with autism spectrum disorderPotential role in transposon silencing (genome stability)
04

Safety considerations

Loss of function related to male sterility due to impaired piRNA stability and germline genome defense.No known direct safety issues with pharmacological targeting or therapeutic modulation (as of current knowledge)
05

Biomarkers

Potential biomarker for spermatogenic failure (azoospermia); no established clinical biomarkers

Beyond the preview

Go deeper on HEN methyltransferase 1 (HENMT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HEN methyltransferase 1 (HENMT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call